Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hilberink JR"'
Autor:
Ortiz Rojas CA; Hematology Division, Department of Internal Medicine, Laboratório de Investigação Médica (LIM) 31, Hospital das Clínicas HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, Universidade de São Paulo, São Paulo, São Paulo, Brazil.; Center for Cell-Based Therapy, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Pereira-Martins DA; Hematology Division, Department of Internal Medicine, Laboratório de Investigação Médica (LIM) 31, Hospital das Clínicas HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, Universidade de São Paulo, São Paulo, São Paulo, Brazil.; Center for Cell-Based Therapy, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Bellido More CC; Department of Pediatrics, Ribeirao Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Sternadt D; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Weinhäuser I; Hematology Division, Department of Internal Medicine, Laboratório de Investigação Médica (LIM) 31, Hospital das Clínicas HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, Universidade de São Paulo, São Paulo, São Paulo, Brazil.; Center for Cell-Based Therapy, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Hilberink JR; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Coelho-Silva JL; Center for Cell-Based Therapy, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.; Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Thomé CH; Hematology Division, Department of Internal Medicine, Laboratório de Investigação Médica (LIM) 31, Hospital das Clínicas HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, Universidade de São Paulo, São Paulo, São Paulo, Brazil., Ferreira GA; Hematology Division, Department of Internal Medicine, Laboratório de Investigação Médica (LIM) 31, Hospital das Clínicas HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, Universidade de São Paulo, São Paulo, São Paulo, Brazil., Ammatuna E; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Huls G; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Valk PJ; Erasmus University Medical Center, Rotterdam, The Netherlands., Schuringa JJ; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Rego EM; Hematology Division, Department of Internal Medicine, Laboratório de Investigação Médica (LIM) 31, Hospital das Clínicas HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, Universidade de São Paulo, São Paulo, São Paulo, Brazil.; Center for Cell-Based Therapy, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Jun; Vol. 204 (6), pp. 2287-2300. Date of Electronic Publication: 2024 Apr 23.
Autor:
Weinhäuser I; Department of Experimental Hematology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands; Department of Internal Medicine, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil; Center for Cell Based Therapy, University of São Paulo, Ribeirao Preto, Brazil; Authors contributed equally to this study., Pereira-Martins DA; Department of Experimental Hematology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands; Department of Internal Medicine, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil; Center for Cell Based Therapy, University of São Paulo, Ribeirao Preto, Brazil; Authors contributed equally to this study., Hilberink JR; Department of Experimental Hematology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands; Authors contributed equally to this study., Brouwers-Vos A; Department of Experimental Hematology, University Medical Centre Groningen, University of Groningen, Groningen., Rego EM; Center for Cell Based Therapy, University of São Paulo, Ribeirao Preto., Huls G; Department of Experimental Hematology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands; Lead contact authors., Schuringa JJ; Department of Experimental Hematology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands; Lead contact authors. j.j.schuringa@umcg.nl.
Publikováno v:
Haematologica [Haematologica] 2024 Feb 01; Vol. 109 (2), pp. 639-645. Date of Electronic Publication: 2024 Feb 01.
Autor:
Hilberink JR; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., van Zeventer IA; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Chitu DA; Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Pabst T; Department of Oncology, University Hospital, Inselspital, and University of Bern, Bern, Switzerland., Klein SK; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.; Department of Internal Medicine, Meander Hospital Amersfoort, Amersfoort, the Netherlands., Stussi G; Department of Hematology, Oncology Institute of Southern Switzerland, Ospedale Regionale, Bellinzona, Switzerland., Griskevicius L; Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania., Valk PJM; Department of Hematology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Cloos J; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., van de Loosdrecht AA; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Breems D; Department of Hematology, ZNA Stuivenberg/Middelheim, Antwerp, Belgium., van Lammeren-Venema D; Department of Hematology, Hagaziekenhuis, Den Haag, the Netherlands., Boersma R; Department of Hematology, Amphia Hospital, Breda, the Netherlands., Jongen-Lavrencic M; Department of Hematology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Fehr M; Department of Medical oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland., Hoogendoorn M; Department of Hematology, Medical Center Leeuwarden, Leeuwarden, the Netherlands., Manz MG; Department of Medical Oncology and Hematology, Universitätsspital Zurich, Zurich, Switzerland., Söhne M; Department of Hematology, Antonius Hospital, Nieuwegein, the Netherlands., van Marwijk Kooy R; Department of Hematology, Isala Hospital, Zwolle, the Netherlands., Deeren D; Department of Hematology, AZ Delta Roeselare, Roeselare, Belgium., van der Poel MWM; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Legdeur MC; Department of Hematology, Medical Spectrum Twente, Enschede, the Netherlands., Tick L; Department of hematology, Maxima Medical Center, Veldhoven, the Netherlands., Chalandon Y; Division of hematology, University Hospital Genève and Faculty of Medicine, University of Genève, Genève, Switzerland., Ammatuna E; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Blum S; Service and Central Laboratory of Hematology, Department of Oncology and Department of Laboratory Medicine and Pathology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Löwenberg B; Department of Hematology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Ossenkoppele GJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Huls G; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands. g.huls@umcg.nl.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2023 Jun 19; Vol. 13 (1), pp. 93. Date of Electronic Publication: 2023 Jun 19.
Autor:
Weinhäuser I; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.; Department of Internal Medicine, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.; Center for Cell Based Therapy, University of São Paulo, Ribeirao Preto, Brazil., Pereira-Martins DA; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.; Department of Internal Medicine, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.; Center for Cell Based Therapy, University of São Paulo, Ribeirao Preto, Brazil., Almeida LY; Department of Internal Medicine, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil., Hilberink JR; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., Silveira DRA; Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King's College London, London, SE5 8AF, UK., Quek L; Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King's College London, London, SE5 8AF, UK., Ortiz C; Department of Internal Medicine, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.; Center for Cell Based Therapy, University of São Paulo, Ribeirao Preto, Brazil., Araujo CL; Department of Internal Medicine, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil., Bianco TM; Department of Internal Medicine, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil., Lucena-Araujo A; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Mota JM; Medical Oncology Service, Sao Paulo State Cancer Institute, University of Sao Paulo, Brazil., Hogeling SM; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., Sternadt D; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., Visser N; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., Diepstra A; Department of Pathology and Medical Biology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., Ammatuna E; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., Huls G; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., Rego EM; Center for Cell Based Therapy, University of São Paulo, Ribeirao Preto, Brazil., Schuringa JJ; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
Publikováno v:
Science advances [Sci Adv] 2023 Apr 14; Vol. 9 (15), pp. eadf8522. Date of Electronic Publication: 2023 Apr 14.
Autor:
Lima K; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil., Pereira-Martins DA; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Department of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., de Miranda LBL; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil., Coelho-Silva JL; Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Leandro GDS; Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil., Weinhäuser I; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Department of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Cavaglieri RC; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil., Leal AM; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil., da Silva WF; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil., Lange APAL; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil., Velloso EDRP; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil., Griessinger E; Department of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Hilberink JR; Department of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Ammatuna E; Department of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Huls G; Department of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Schuringa JJ; Department of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Rego EM; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil. eduardo.rego@fm.usp.br., Machado-Neto JA; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. jamachadoneto@usp.br.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2022 Nov 09; Vol. 12 (11), pp. 151. Date of Electronic Publication: 2022 Nov 09.
Autor:
Cruijsen M; Department of Hematology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands. marjan.cruijsen@catharinaziekenhuis.nl.; Catharina Hospital Eindhoven, Eindhoven, Netherlands. marjan.cruijsen@catharinaziekenhuis.nl., Hilberink JR; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., van der Velden WJFM; Department of Hematology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands., Jansen JH; Department of Laboratory Medicine, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands., Bär B; Department of Hematology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands., Schaap NPM; Department of Hematology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands., de Haan A; Department for Health Evidence, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands., Mulder AB; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Groot MR; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Baron F; Department of Hematology, CHU and University of Liège, Liège, Belgium., Vellenga E; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Blijlevens NNM; Department of Hematology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands., Huls G; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2021 Aug; Vol. 56 (8), pp. 1964-1970. Date of Electronic Publication: 2021 Apr 06.
Autor:
Han SY; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN., Mrózek K; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Voutsinas J; Clinical Biostatistics, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Wu Q; Clinical Biostatistics, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Morgan EA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Vestergaard H; Mastocytosis Center and.; Department of Hematology, Odense University Hospital, Odense, Denmark., Ohgami R; Department of Pathology, Stanford University, Stanford, CA., Kluin PM; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Kristensen TK; Mastocytosis Center and.; Department of Pathology, Odense University Hospital, Odense, Denmark., Pullarkat S; Department of Pathology, University of California, Los Angeles, CA., Møller MB; Mastocytosis Center and.; Department of Pathology, Odense University Hospital, Odense, Denmark., Schiefer AI; Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria., Baughn LB; Division of Hematopathology, Mayo Clinic, Rochester, MN.; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN., Kim Y; Department of Pathology, City of Hope National Medical Center, Duarte, CA., Czuchlewski D; Department of Pathology, University of New Mexico, Albuquerque, NM., Hilberink JR; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Horny HP; Institute of Pathology, Ludwig-Maximilian University, Munich, Germany., George TI; Department of Pathology, University of New Mexico, Albuquerque, NM.; Department of Pathology, University of Utah, Salt Lake City, UT., Dolan M; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN., Ku NK; Department of Pathology, University of California, Los Angeles, CA., Arana Yi C; Department of Pathology, University of New Mexico, Albuquerque, NM., Pullarkat V; Division of Hematology and HCT, City of Hope National Medical Center, Duarte, CA., Kohlschmidt J; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Salhotra A; Division of Hematology and HCT, City of Hope National Medical Center, Duarte, CA., Soma L; Clinical Reseach Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA., Bloomfield CD; Comprehensive Cancer Center, The Ohio State University, Columbus, OH., Chen D; Division of Hematopathology, Mayo Clinic, Rochester, MN., Sperr WR; Division of Hematology and Hemostaseology, Department of Internal Medicine I, and.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Marcucci G; Division of Hematology and HCT, City of Hope National Medical Center, Duarte, CA., Cho C; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College; New York, NY., Akin C; Division of Allergy and Clinical Immunology, University of Michigan, Ann Arbor, Michigan, MI., Gotlib J; Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, CA., Broesby-Olsen S; Mastocytosis Center and.; Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis, Odense, Denmark., Larson M; Division of Hematology, Oncology and Cell Therapy, Rush University, Chicago, IL., Linden MA; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN., Deeg HJ; Clinical Reseach Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA., Hoermann G; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.; Central Institute of Medical and Chemical Laboratory Diagnostics, University Hospital Innsbruck, Innsbruck, Austria., Perales MA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College; New York, NY., Hornick JL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Litzow MR; Department of Internal Medicine and.; Division of Hematology, Mayo Clinic, Rochester, MN., Nakamura R; Division of Hematology and HCT, City of Hope National Medical Center, Duarte, CA., Weisdorf D; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN., Borthakur G; Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX; and., Huls G; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Valent P; Division of Hematology and Hemostaseology, Department of Internal Medicine I, and.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Ustun C; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN.; Division of Hematology, Oncology and Cell Therapy, Rush University, Chicago, IL., Yeung CCS; Clinical Reseach Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA.
Publikováno v:
Blood advances [Blood Adv] 2021 May 25; Vol. 5 (10), pp. 2481-2489.
Autor:
Hilberink JR; Department of Hematology, University Medical Center Groningen, University of Groningen, The Netherlands. Electronic address: j.r.hilberink@umcg.nl., Morsink LM; Department of Hematology, University Medical Center Groningen, University of Groningen, The Netherlands., van der Velden WJFM; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Mulder AB; Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, The Netherlands., Hazenberg CLE; Department of Hematology, University Medical Center Groningen, University of Groningen, The Netherlands., de Groot M; Department of Hematology, University Medical Center Groningen, University of Groningen, The Netherlands., Choi G; Department of Hematology, University Medical Center Groningen, University of Groningen, The Netherlands., Schuringa JJ; Department of Hematology, University Medical Center Groningen, University of Groningen, The Netherlands., Meijer K; Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, The Netherlands., Blijlevens NMA; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Ammatuna E; Department of Hematology, University Medical Center Groningen, University of Groningen, The Netherlands., Huls G; Department of Hematology, University Medical Center Groningen, University of Groningen, The Netherlands.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2021 Mar; Vol. 27 (3), pp. 246-252. Date of Electronic Publication: 2020 Dec 17.
Autor:
Ustun C; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota., Morgan E; Department of Pathology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts., Moodie EEM; Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Quebec, Canada., Pullarkat S; Department of Pathology, University of California, Los Angeles, California., Yeung C; Fred Hutchinson Cancer Research Center, Seattle, Washington.; University of Washington School of Medicine, Seattle, Washington., Broesby-Olsen S; Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis, Odense, Denmark.; Mastocytosis Center Odense University Hospital, Odense, Denmark., Ohgami R; Department of Pathology, Stanford University, Stanford, California., Kim Y; Department of Pathology, City of Hope National Medical Center, Duarte, California., Sperr W; Division of Hematology & Hemostaseology, Ludwig Boltzmann Cluster Oncology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria., Vestergaard H; Mastocytosis Center Odense University Hospital, Odense, Denmark.; Department of Hematology, Odense University Hospital, Odense, Denmark., Chen D; Department of Pathology, Mayo Clinic, Rochester, Minnesota., Kluin PM; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Dolan M; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota., Mrózek K; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Czuchlewski D; Department of Pathology, University of New Mexico, Albuquerque, New Mexico., Horny HP; Institute of Pathology, Ludwig-Maximilians-University, Munich, Germany., George TI; Department of Pathology, University of New Mexico, Albuquerque, New Mexico.; Department of Pathology, University of Utah, Salt Lake City, Utah., Kristensen TK; Mastocytosis Center Odense University Hospital, Odense, Denmark.; Department of Pathology, Odense University Hospital, Odense, Denmark., Ku NK; Department of Pathology, University of California, Los Angeles, California., Yi CA; Department of Pathology, University of New Mexico, Albuquerque, New Mexico., Møller MB; Mastocytosis Center Odense University Hospital, Odense, Denmark.; Department of Pathology, Odense University Hospital, Odense, Denmark., Marcucci G; Division of Hematology and HCT, City of Hope, Duarte, California., Baughn L; Department of Pathology, Mayo Clinic, Rochester, Minnesota.; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota., Schiefer AI; Department of Pathology, Medical University of Vienna, Vienna, Austria., Hilberink JR; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Pullarkat V; Division of Hematology and HCT, City of Hope, Duarte, California., Shanley R; Biostatistics and Bioinformatics, University of Minnesota, Minneapolis, Minnesota., Kohlschmidt J; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.; Alliance Statistics and Data Center, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Coulombe J; Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Quebec, Canada., Salhotra A; Division of Hematology and HCT, City of Hope, Duarte, California., Soma L; Fred Hutchinson Cancer Research Center, Seattle, Washington.; University of Washington School of Medicine, Seattle, Washington., Cho C; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, New York., Linden MA; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota., Akin C; Department of Pathology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts.; Division of Allergy and Clinical Immunology, University of Michigan, Ann Arbor, Michigan., Gotlib J; Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, California., Hoermann G; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Hornick J; Department of Pathology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts., Nakamura R; Division of Hematology and HCT, City of Hope, Duarte, California., Deeg J; Fred Hutchinson Cancer Research Center, Seattle, Washington.; University of Washington School of Medicine, Seattle, Washington., Bloomfield CD; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Weisdorf D; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota., Litzow MR; Department of Internal Medicine and Division of Hematology, Mayo Clinic, Rochester, Minnesota., Valent P; Division of Hematology & Hemostaseology, Ludwig Boltzmann Cluster Oncology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria., Huls G; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Perales MA; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, New York., Borthakur G; Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Publikováno v:
Cancer medicine [Cancer Med] 2018 Sep; Vol. 7 (9), pp. 4447-4455. Date of Electronic Publication: 2018 Aug 16.